{
  "id": 12661773,
  "title": "WHO Recommends Against GLP-1s For Young Kids—Amid Wegovy Trial For 6 Year Olds",
  "url": "https://urgent.news/2026/10/07/who-recommends-against-glp-1s-for-young-kids-amid-wegovy-trial-for-6",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T15:06:11.000Z",
  "source": {
    "name": "Forbes",
    "slug": "forbes",
    "url": "https://www.forbes.com/sites/maryroeloffs/2026/10/07/who-recommends-against-glp-1s-for-young-kids-amid-wegovy-trial-for-6-year-olds/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Despite a nearly 600% surge in adolescent GLP-1 prescriptions, the WHO says they may pose critical safety risks to growing bodies.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}